UPDATE : Friday, July 3, 2020
상단여백
Whistleblowers, shareholders furious over Medytox’s rebuttal
The whistleblowers who revealed Medytox’s alleged illegal manufacturing of ...
by Jeong Sae-im  |  2020-04-21 15:19
라인
ImmuneMed confident of drug candidate’s effect on Covid-19
ImmuneMed said its inflammatory viral disease treatment HzVSF (humanized vi...
by Jeong Sae-im  |  2020-04-21 13:23
라인
Medytox files suit to cancel administrative order
Medytox has filed a lawsuit against the Ministry of Food and Drug Safety to...
by Shim Hyun-tai  |  2020-04-20 16:37
라인
DM Bio signs CDMO contract with Abion for antibody treatment
DM Bio said it has signed a CDMO (contract development and manufacturing or...
by Shim Hyun-tai  |  2020-04-17 16:03
라인
Medytox CEO charged with making, selling botulinum toxin illegally
Prosecutors said Friday they have indicted Medytox CEO Jung Hyun-ho on char...
by Jeong Sae-im  |  2020-04-17 16:00
라인
Researchers to test asthma drug to treat Covid-19
Local infectious disease specialists said they would evaluate the potential...
by Kim Yun-mi  |  2020-04-16 16:20
라인
Bukwang to test its antiviral drug against Covid-19
Bukwang Pharm said its hepatitis B treatment Levovir (ingredient: clevudine...
by Jeong Sae-im  |  2020-04-16 12:20
라인
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer ...
by Kim Yun-mi  |  2020-04-16 10:48
라인
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide
Institut Pasteur Korea, an institute specializing in infectious diseases, a...
by Shim Hyun-tai  |  2020-04-14 17:49
라인
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
Gilead Sciences’ last-minute modification of the clinical design of remdesi...
by Kim Yun-mi  |  2020-04-10 15:36
라인
Executive salaries highest at Samsung Biologics, Celltrion
Samsung Biologics recorded the widest salary gap between its executives and...
by Jeong Sae-im  |  2020-04-09 11:13
라인
Review of cancer drug benefits delayed amid social distancing
The government has postponed the health authorities’ meeting for a review o...
by Kim Yun-mi  |  2020-04-08 13:46
라인
Jeil’s oral cancer treatment wins extended indication for NSCLC
Jeil Pharmaceutical said Monday that its oral anticancer drug, Ts-1, has ob...
by Shim Hyun-tai  |  2020-04-06 15:33
라인
Pfizer, MSD put off reorganizing due to COVID-19
Pfizer and MSD have postponed their scheduled organizational reshuffle beca...
by Kim Yun-mi  |  2020-04-03 17:09
라인
GC Pharma to supply plasma treatment for COVID-19 this year
GC Pharma said Thursday that it plans to commercialize GC5131A, the world&#...
by Shim Hyun-tai  |  2020-04-02 18:11
라인
Genexine to release results of using Hyleukin-7 & Keytruda at ASCO
Genexine said Wednesday that its poster presentation has won the approval f...
by Shim Hyun-tai  |  2020-04-02 17:01
라인
AptaBio wins patent for blood cancer therapy
AptaBio, a biopharmaceutical developer of anticancer and diabetic complicat...
by Shim Hyun-tai  |  2020-04-02 16:17
라인
Venclexta extended survival in first-line acute myeloid leukemia
AbbVie said combining Venclexta (ingredient: venetoclax), a treatment for c...
by Kim Yoon-mi  |  2020-04-02 15:31
라인
‘More public-private partnership needed to spur research of less-profitable areas’
The new coronavirus pandemic has affected more than 800,000 people around t...
by You Ji-young  |  2020-04-01 18:58
라인
GC partner applies for permit of Hunterase ICV to Japan
GC Pharma said Tuesday that its partner, Clinigen K.K., has applied for the...
by Shim Hyun-tai  |  2020-04-01 18:47
여백
여백
여백
Back to Top